Can computationally designed binders against alpha-synuclein realistically translate to in vivo efficacy, or will BBB penetration and immunogenicity be fatal obstacles?

De Novo Binder Design Targeting Alpha-Synuclein Aggregation Interface

Debate Transcript

No transcript rounds recorded for this debate.